Clinical Trial Update: Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the biological effects of combining nab-paclitaxel with gemcitabine in metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Pancreatic Adenocarcinoma | Phase 1 | Status: COMPLETED